Table 1.
In-vitro inhibition of haemagglutination of human red blood cells (HRBCs)
| Straina | Susceptibility to β-lactams | Adhesins | HRBC assay (titre)b
|
||
|---|---|---|---|---|---|
| 3Pl (n = 8) | 1UE + 2Pl (n = 8) | 3UE (n = 8) | |||
| NECS20575 | S | papG+/fimH+ | 1/128 | 1/8 | 0 |
| NECS29787 | S | papG+/fimH+ | 1/256 | 1/8 | 0 |
| NEC13 | TEM-3 | papG−/fimH+ | 1/8 | 1/1 | 0 |
| NEC5 | CTX-M-15 | papG−/fimH− | NA | NA | NA |
3Pl, regimen with three capsules of placebo; 1UE + 2Pl, regimen with one cranberry capsule and two placebo capsules; 3UE, regimen with three cranberry capsules; NA, not applicable; S, susceptible.
a
The results are representative of at least four independent trials for each strain.
b
Results indicate the final dilution at which agglutination suppression by the bacterial suspensions was observed.